Alpha Tau Medical (DRTS) Current Leases (2022 - 2026)
Alpha Tau Medical (DRTS) posted Current Leases of $1.2 million for Q1 2026, up 6.19% sequentially from $1.1 million in Q4 2025, and up 19.98% YoY from $1.0 million in Q1 2025.
Alpha Tau Medical (DRTS) Current Leases (2022 - 2026) Analysis & Trends
Alpha Tau Medical has reported Current Leases for 5 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Current Leases rose 19.98% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 19.98% YoY) and the FY2025 annual result came in at $1.1 million, up 11.87% from the prior year.
- Current Leases improved to $1.2 million in Q1 2026 per DRTS's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Leases peaked at $1.2 million in Q1 2026 and troughed at $669000.0 in Q4 2022.
- A 5-year average of $993500.0 and a median of $1.0 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases soared 58.74% in 2023, then retreated 4.8% in 2024.
- Over 5 years, Current Leases stood at $669000.0 in 2022, then soared by 58.74% to $1.1 million in 2023, then slipped by 4.8% to $1.0 million in 2024, then rose by 11.87% to $1.1 million in 2025, then increased by 6.19% to $1.2 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.2 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 848,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 828,000.00 |
| Dec 31, 2022 | 669,000.00 |